Injective’s CEO was in Washington yesterday.
Eric Chen met with officials from the White House, the SEC, and the CFTC. He was joined by @injective General Counsel, Head of Policy, and Head of Research.
While a lot of crypto projects talk about “working with regulators,” Injective has actually been building the infrastructure to operate inside the existing rules:
• They became an SEC-registered transfer agent in August, so tokenized securities on Injective can have official ownership records.
• ethereum:0xe28b3b32b6c345a34ff64674606124dd5aceca30 is one of the few crypto assets that already has CFTC-regulated futures listed in the U.S.
• They built Injective Mint so issuers can bring real-world assets onchain in a compliant way.
• Last year they proposed a temporary exemption for DeFi builders to the SEC’s Crypto Task Force. The SEC later released its Innovation Exemption, and Injective is pushing to expand it so more American teams can launch here instead of going offshore.
• They also filed a comment letter arguing that DeFi lending shouldn’t be treated as a securities transaction.
• Their summit brought White House officials, senators, and members of Congress from both parties into the same room to talk about onchain finance.
• Their Policy Institute is still working with lawmakers on clearer rules for tokenization, DeFi, and onchain perpetuals.
The point they’re making is straightforward: the rules for tokenized markets are being written right now, and Injective is sitting at the table while it happens.
Want exposure to ethereum:0xe28b3b32b6c345a34ff64674606124dd5aceca30 You’ve actually got two real options.
You can buy and hold the token yourself, or you can buy shares of the upcoming Canary Staked INJ ETF (ticker: INJC) through a normal brokerage account.
Holding @injective directly
•You own the actual tokens.
•You control your own wallet and keys.
•You can stake, vote on governance, and use INJ across Injective apps.
•You deal with exchange fees, network fees, and validator commissions if you stake.
Buying INJC shares
•You own shares in a fund that holds and stakes INJ for you.
•Everything lives in your regular brokerage account (same place you hold stocks).
•The fund takes a sponsor fee and a cut of staking rewards. You also pay whatever commissions or spreads your broker charges.
Important differences
• One INJC share is not equal to one INJ. The share price moves with INJ (plus staking rewards, minus fees), but it won’t track perfectly because the fund pays expenses in INJ and adds staking rewards back in.
• INJC only trades during stock-market hours. INJ trades 24/7.
• You can’t redeem INJC shares for actual INJ tokens. You can only buy and sell the shares.
• Staking rewards stay inside the fund and show up in the share value, they aren’t paid out as cash.
• The fund holds spot INJ (no futures or leverage).
Chat i tested https://t.co/rTkGe5BFsz against Jupiter and Raydium to answer a simple question:
“does using a DEX aggregator actually mean you’re getting the best price?”
same token pair. same input amount. quotes taken one minute apart.
the result wasn’t what a @swapdotio promo thread would make you expect 😂
See thread below 🧵
Not debating tokenomics. But I’d rather see a growing business first.
Pyth just reported $11.49M ARR and 86% QoQ growth, then introduced a policy directing 100% of DAO receipts from Pyth products toward monthly $PYTH purchases.
I just think revenue-backed discussions are fun.
The buyback announcement is getting most of the attention.
What stands out to me is that Pyth closed Q3 at $11.49M ARR, up 86% QoQ.
The 100% Rule is interesting because it creates a direct link between business performance and DAO purchases. More customers and more product revenue means more receipts flowing into the mechanism.
The buyback is the headline.
The revenue growth is the story I’m watching.
Binance was always the obvious gap.
most firms already rely on it for price discovery, but every venue usually comes with its own integration burden.
now the conversation isn’t prediction markets.
the catalog is starting to look a lot closer to the markets traders actually use